ACACA and metabolic dysfunction-associated steatohepatitis: It is known that increased hepatic DNL contributes to NASH, while the rate-limiting step in DNL is catalyzed by Acetyl-CoA carboxylase (ACC), suggesting inhibition of ACC represents an attractive approach for the treatment of NASH (263).